Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach

Total article views   HTML views PDF downloads Totals
5,852 Dovepress* 5,387+ 1,101 6,488
PubMed Central* 465 158 623
Totals 5,852 1,259 7,111
*Since 16 April 2020

View citations on PubMed Central and Google Scholar